Genetic amniocentesis in women 20-34 years old: associated risks

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Reproductive Health

Background:

• Genetic amniocentesis is a common prenatal diagnostic procedure.
• Understanding factors influencing procedure-related fetal loss is crucial for informed consent and risk assessment.
• Previous studies have suggested potential links between maternal history and pregnancy outcomes.

Purpose of the Study:

• To evaluate the impact of predisposing maternal factors on amniocentesis-related fetal loss.
• To compare fetal loss rates between women undergoing genetic amniocentesis and a low-risk control group.
• To identify specific risk factors associated with increased fetal loss post-amniocentesis.

Main Methods:

• Retrospective controlled study of 3910 women (20-34 years) undergoing genetic amniocentesis (study group) and 5324 controls (under 35, low Down syndrome risk).
• Analysis of fetal losses (up to 28 weeks) in relation to maternal historical conditions (previous abortions) and bleeding during current pregnancy.
• Comparison of fetal loss rates between the study and control groups, and within subgroups based on predisposing factors.

Main Results:

• Total fetal loss rate was 2.1% in the study group versus 1.5% in controls.
• A history of previous spontaneous or induced abortions and bleeding during pregnancy were significantly associated with increased fetal loss in both groups.
• In cases with no predisposing factors, the added fetal loss rate after amniocentesis was a non-significant 0.03%.

Conclusions:

• Previous abortions and bleeding during pregnancy are significant risk factors for fetal loss following amniocentesis.
• For women without these predisposing factors, genetic amniocentesis carries a minimal and non-significant added risk of fetal loss.
• Risk stratification based on maternal history can help counsel patients undergoing genetic amniocentesis.